- Home
- PRLD vs SWZ Comparison
PRLD vs SWZ Comparison
Compare PRLD & SWZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRLD
- SWZ
- Stock Information
- Founded
- PRLD 2016
- SWZ 1986
- Country
- PRLD United States
- SWZ United States
- Employees
- PRLD N/A
- SWZ N/A
- Industry
- PRLD Medicinal Chemicals and Botanical Products
- SWZ Finance Companies
- Sector
- PRLD Health Care
- SWZ Finance
- Exchange
- PRLD Nasdaq
- SWZ Nasdaq
- Market Cap
- PRLD 69.1M
- SWZ 78.7M
- IPO Year
- PRLD 2020
- SWZ N/A
- Fundamental
- Price
- PRLD $1.58
- SWZ $5.99
- Analyst Decision
- PRLD Strong Buy
- SWZ
- Analyst Count
- PRLD 3
- SWZ 0
- Target Price
- PRLD $4.00
- SWZ N/A
- AVG Volume (30 Days)
- PRLD 258.3K
- SWZ 14.2K
- Earning Date
- PRLD 10-31-2025
- SWZ 01-01-0001
- Dividend Yield
- PRLD N/A
- SWZ 6.59%
- EPS Growth
- PRLD N/A
- SWZ N/A
- EPS
- PRLD N/A
- SWZ N/A
- Revenue
- PRLD $7,000,000.00
- SWZ N/A
- Revenue This Year
- PRLD N/A
- SWZ N/A
- Revenue Next Year
- PRLD N/A
- SWZ N/A
- P/E Ratio
- PRLD N/A
- SWZ N/A
- Revenue Growth
- PRLD N/A
- SWZ N/A
- 52 Week Low
- PRLD $0.61
- SWZ $7.12
- 52 Week High
- PRLD $1.91
- SWZ $8.57
- Technical
- Relative Strength Index (RSI)
- PRLD 57.91
- SWZ 34.26
- Support Level
- PRLD $1.49
- SWZ $5.98
- Resistance Level
- PRLD $1.72
- SWZ $6.08
- Average True Range (ATR)
- PRLD 0.17
- SWZ 0.08
- MACD
- PRLD 0.02
- SWZ 0.00
- Stochastic Oscillator
- PRLD 75.44
- SWZ 20.83
About PRLD Prelude Therapeutics Incorporated
Prelude Therapeutics Incorp is a clinical stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet needs. The company's pipeline includes four candidates currently in clinical development: PRT1419, a potent, selective inhibitor of MCL1; PRT2527, a potent and selective CDK9 inhibitor, PRT3645, a next-generation CDK4/6 inhibitor, and PRT3789 a first-in-class SMARCA2/BRM protein degrader.
About SWZ Swiss Helvetia Fund Inc. (The)
Swiss Helvetia Fund Inc is a non-diversified, closed-end investment company. Its investment objective is to seek long-term capital appreciation through investment in equity and equity-linked securities of Swiss companies. The group invests in various sectors such as pharmaceuticals, food and beverage, industrial goods and services, banks, personal and household goods, construction and materials, biotechnology, medical equipment, chemicals, technology, financial services, insurance, Semiconductors, Information Technology, and retail.